Cargando…
Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study
In clinically organ-confined prostate cancer patients, bloodstream tumour cell dissemination generally occurs, and may be enhanced by surgical prostate manipulation. To evaluate cancer-cell seeding impact upon patient recurrence-free survival, 155 patients were prospectively enrolled then followed....
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653745/ https://www.ncbi.nlm.nih.gov/pubmed/19223910 http://dx.doi.org/10.1038/sj.bjc.6604912 |
_version_ | 1782165307002978304 |
---|---|
author | Eschwège, P Moutereau, S Droupy, S Douard, R Gala, J-L Benoit, G Conti, M Manivet, P Loric, S |
author_facet | Eschwège, P Moutereau, S Droupy, S Douard, R Gala, J-L Benoit, G Conti, M Manivet, P Loric, S |
author_sort | Eschwège, P |
collection | PubMed |
description | In clinically organ-confined prostate cancer patients, bloodstream tumour cell dissemination generally occurs, and may be enhanced by surgical prostate manipulation. To evaluate cancer-cell seeding impact upon patient recurrence-free survival, 155 patients were prospectively enrolled then followed. Here, 57 patients presented blood prostate cell shedding preoperatively and intraoperatively (group I). Of the 98 preoperatively negative patients, 53 (54%) remained negative (group II) and 45 (46%) became intraoperatively positive (group III). Median biological and clinical recurrence-free time was far shorter in group I (36.2 months, P<0.0001) than in group II (69.6 months) but did not significantly differ in group II and III (69.6 months vs 65.0). Such 5-year follow-up data show that preoperative circulating prostate cells are an independent prognosis factor of recurrence. Moreover, tumour handling induces cancer-cell seeding but surgical blood dissemination does not accelerate cancer evolution. |
format | Text |
id | pubmed-2653745 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-26537452010-02-24 Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study Eschwège, P Moutereau, S Droupy, S Douard, R Gala, J-L Benoit, G Conti, M Manivet, P Loric, S Br J Cancer Clinical Study In clinically organ-confined prostate cancer patients, bloodstream tumour cell dissemination generally occurs, and may be enhanced by surgical prostate manipulation. To evaluate cancer-cell seeding impact upon patient recurrence-free survival, 155 patients were prospectively enrolled then followed. Here, 57 patients presented blood prostate cell shedding preoperatively and intraoperatively (group I). Of the 98 preoperatively negative patients, 53 (54%) remained negative (group II) and 45 (46%) became intraoperatively positive (group III). Median biological and clinical recurrence-free time was far shorter in group I (36.2 months, P<0.0001) than in group II (69.6 months) but did not significantly differ in group II and III (69.6 months vs 65.0). Such 5-year follow-up data show that preoperative circulating prostate cells are an independent prognosis factor of recurrence. Moreover, tumour handling induces cancer-cell seeding but surgical blood dissemination does not accelerate cancer evolution. Nature Publishing Group 2009-02-24 2009-02-17 /pmc/articles/PMC2653745/ /pubmed/19223910 http://dx.doi.org/10.1038/sj.bjc.6604912 Text en Copyright © 2009 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Clinical Study Eschwège, P Moutereau, S Droupy, S Douard, R Gala, J-L Benoit, G Conti, M Manivet, P Loric, S Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study |
title | Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study |
title_full | Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study |
title_fullStr | Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study |
title_full_unstemmed | Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study |
title_short | Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study |
title_sort | prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653745/ https://www.ncbi.nlm.nih.gov/pubmed/19223910 http://dx.doi.org/10.1038/sj.bjc.6604912 |
work_keys_str_mv | AT eschwegep prognosticvalueofprostatecirculatingcellsdetectioninprostatecancerpatientsaprospectivestudy AT moutereaus prognosticvalueofprostatecirculatingcellsdetectioninprostatecancerpatientsaprospectivestudy AT droupys prognosticvalueofprostatecirculatingcellsdetectioninprostatecancerpatientsaprospectivestudy AT douardr prognosticvalueofprostatecirculatingcellsdetectioninprostatecancerpatientsaprospectivestudy AT galajl prognosticvalueofprostatecirculatingcellsdetectioninprostatecancerpatientsaprospectivestudy AT benoitg prognosticvalueofprostatecirculatingcellsdetectioninprostatecancerpatientsaprospectivestudy AT contim prognosticvalueofprostatecirculatingcellsdetectioninprostatecancerpatientsaprospectivestudy AT manivetp prognosticvalueofprostatecirculatingcellsdetectioninprostatecancerpatientsaprospectivestudy AT lorics prognosticvalueofprostatecirculatingcellsdetectioninprostatecancerpatientsaprospectivestudy |